Suppr超能文献

1054 例乳腺癌阴性西班牙裔人群中 PALB2、CHEK2 和其他已知乳腺癌易感基因的致病性和可能致病性变异体。

Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer.

机构信息

Division of Clinical Cancer Genomics, City of Hope, Duarte, California.

Clinical Cancer Genomics Community Research Network, Los Angeles, California.

出版信息

Cancer. 2019 Aug 15;125(16):2829-2836. doi: 10.1002/cncr.32083. Epub 2019 Jun 17.

Abstract

BACKGROUND

Breast cancer (BC) is the most common cancer and related cause of mortality among Hispanics, yet susceptibility has been understudied. BRCA1 and BRCA2 (BRCA) mutations explain less than one-half of hereditary BC, and the proportion associated with other BC susceptibility genes is unknown.

METHODS

Germline DNA from 1054 BRCA-mutation-negative Hispanic women with hereditary BC (BC diagnosed at age <51 years, bilateral BC, breast and ovarian cancer, or BC diagnosed at ages 51-70 years with ≥2 first-degree or second-degree relatives who had BC diagnosed at age <70 years), 312 local controls, and 887 multiethnic cohort controls was sequenced and analyzed for 12 known and suspected, high-penetrance and moderate-penetrance cancer susceptibility genes (ataxia telangiectasia mutated [ATM], breast cancer 1 interacting protein C-terminal helicase 1 [BRIP1], cadherin 1 [CDH1], checkpoint kinase 2 [CHEK2], nibrin [NBN], neurofibromatosis type 1 [NF1], partner and localizer of BRCA2 [PALB2], phosphatase and tensin homolog [PTEN], RAD51 paralog 3 [RAD51C], RAD51D, serine/threonine kinase 11 [STK11], and TP53).

RESULTS

Forty-nine (4.6%) pathogenic or likely pathogenic variants (PVs) in 47 of 1054 participants (4.5%), including 21 truncating frameshift, 20 missense, 5 nonsense, and 4 splice variants, were identified in CHEK2 (n = 20), PALB2 (n = 18), ATM (n = 5), TP53 (n = 3), BRIP1 (n = 2), and CDH1 and NF1 (both n = 1) and none were identified in NBN, PTEN, STK11, RAD51C, or RAD51D. Nine participants carried the PALB2 c.2167_2168del PV (0.85%), and 14 carried the CHEK2 c.707T>C PV (1.32%).

CONCLUSIONS

Of 1054 BRCA-negative, high-risk Hispanic women, 4.5% carried a PV in a cancer susceptibility gene, increasing understanding of hereditary BC in this population. Recurrent PVs in PALB2 and CHEK2 represented 47% (23 of 49) of the total, suggesting a founder effect. Accurate classification of variants was enabled by carefully controlling for ancestry and the increased identification of at-risk Hispanics for screening and prevention.

摘要

背景

乳腺癌(BC)是西班牙裔人群中最常见的癌症和相关死亡原因,但易感性研究较少。BRCA1 和 BRCA2(BRCA)突变解释了不到一半的遗传性 BC,而与其他 BC 易感性基因相关的比例尚不清楚。

方法

从 1054 名 BRCA 突变阴性的遗传性 BC 西班牙裔女性(BC 诊断年龄<51 岁,双侧 BC、乳腺和卵巢癌,或 BC 诊断年龄 51-70 岁,有≥2 位一级或二级亲属在 70 岁之前诊断为 BC)、312 名当地对照和 887 名多民族队列对照的种系 DNA 进行测序和分析,以确定 12 个已知和可疑的、高外显率和中外显率的癌症易感性基因(共济失调毛细血管扩张突变 [ATM]、乳腺癌 1 相互作用蛋白 C 端解旋酶 1 [BRIP1]、钙粘蛋白 1 [CDH1]、检查点激酶 2 [CHEK2]、核蛋白 [NBN]、神经纤维瘤病 1 [NF1]、BRCA2 的伙伴和定位器 [PALB2]、磷酸酶和张力蛋白同源物 [PTEN]、RAD51 平行物 3 [RAD51C]、RAD51D、丝氨酸/苏氨酸激酶 11 [STK11] 和 TP53)。

结果

在 1054 名参与者中的 47 名(4.6%)中发现了 49 个(4.6%)致病性或可能致病性变异(PV),包括 21 个截断移码、20 个错义、5 个无义和 4 个剪接变异,在 CHEK2(n=20)、PALB2(n=18)、ATM(n=5)、TP53(n=3)、BRIP1(n=2)和 CDH1 和 NF1(均 n=1)中均发现了这些变异,但在 NBN、PTEN、STK11、RAD51C 或 RAD51D 中均未发现这些变异。9 名参与者携带 PALB2 c.2167_2168del PV(0.85%),14 名参与者携带 CHEK2 c.707T>C PV(1.32%)。

结论

在 1054 名 BRCA 阴性的高危西班牙裔女性中,4.5%携带癌症易感性基因的 PV,这增加了对该人群遗传性 BC 的了解。PALB2 和 CHEK2 中的复发性 PV 占总数的 47%(49 个中的 23 个),表明存在一个创始效应。通过仔细控制血统,以及更准确地识别有风险的西班牙裔人进行筛查和预防,从而能够准确分类变异。

相似文献

2
A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes.
Cancer. 2017 May 15;123(10):1721-1730. doi: 10.1002/cncr.30498. Epub 2017 Jan 13.
6
Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
JAMA Oncol. 2017 Sep 1;3(9):1190-1196. doi: 10.1001/jamaoncol.2017.0424.
8
Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in , , , , and .
J Clin Oncol. 2023 Mar 20;41(9):1703-1713. doi: 10.1200/JCO.22.01239. Epub 2023 Jan 9.
10
Rare, protein-truncating variants in , and , but not , are associated with increased breast cancer risks.
J Med Genet. 2017 Nov;54(11):732-741. doi: 10.1136/jmedgenet-2017-104588. Epub 2017 Aug 4.

引用本文的文献

3
Predicting Pathogenic Variants of Breast Cancer Using Ultrasound-Derived Machine Learning Models.
Cancers (Basel). 2025 Mar 18;17(6):1019. doi: 10.3390/cancers17061019.
4
Los olvidados: Non-BRCA variants associated with Hereditary breast cancer in Mexican population.
Breast Cancer Res. 2025 Jan 15;27(1):7. doi: 10.1186/s13058-024-01957-9.
7
Spectrum and characteristics of germline PALB2 pathogenic variants in 1556 early-onset breast cancer patients in China.
J Cancer Res Clin Oncol. 2024 Jun 25;150(6):322. doi: 10.1007/s00432-024-05758-7.
8
Variants Extend the Mutational Profile of Hungarian Patients with Breast and Ovarian Cancer.
Cancers (Basel). 2023 Aug 31;15(17):4350. doi: 10.3390/cancers15174350.
9
Impact of High-to-Moderate Penetrance Genes on Genetic Testing: Looking over Breast Cancer.
Genes (Basel). 2023 Jul 26;14(8):1530. doi: 10.3390/genes14081530.

本文引用的文献

2
National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer.
J Clin Oncol. 2017 Dec 1;35(34):3800-3806. doi: 10.1200/JCO.2017.73.6314. Epub 2017 Aug 18.
3
The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes.
Fam Cancer. 2018 Apr;17(2):235-245. doi: 10.1007/s10689-017-0019-5.
4
The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk.
NPJ Breast Cancer. 2017 Jun 9;3:22. doi: 10.1038/s41523-017-0024-8. eCollection 2017.
5
Genetic Cancer Risk Assessment for Breast Cancer in Latin America.
Rev Invest Clin. 2017 Mar-Apr;69(2):94-102. doi: 10.24875/ric.17002195.
6
Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
JAMA Oncol. 2017 Sep 1;3(9):1190-1196. doi: 10.1001/jamaoncol.2017.0424.
7
Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer.
J Clin Oncol. 2017 Jul 10;35(20):2232-2239. doi: 10.1200/JCO.2016.71.6480. Epub 2017 Apr 12.
8
Haplotype analyses of the c.1027C>T and c.2167_2168delAT recurrent truncating mutations in the breast cancer-predisposing gene PALB2.
Breast Cancer Res Treat. 2016 Nov;160(1):121-129. doi: 10.1007/s10549-016-3981-y. Epub 2016 Sep 13.
9
Analysis of protein-coding genetic variation in 60,706 humans.
Nature. 2016 Aug 18;536(7616):285-91. doi: 10.1038/nature19057.
10
Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers.
J Clin Oncol. 2016 Aug 10;34(23):2750-60. doi: 10.1200/JCO.2016.66.5844. Epub 2016 Jun 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验